{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:58:49Z","timestamp":1790715529032,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":149,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.clinsp.2025.100701","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T19:58:20Z","timestamp":1752609500000},"page":"100701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Expression and clinical significance of MCF2L-AS1 in stomach adenocarcinoma"],"prefix":"10.1016","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7393-9186","authenticated-orcid":false,"given":"Chaowen","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3953-5699","authenticated-orcid":false,"given":"Jun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7739-2395","authenticated-orcid":false,"given":"Bixia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2524-1443","authenticated-orcid":false,"given":"Xiayang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5705-4071","authenticated-orcid":false,"given":"Huihui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clinsp.2025.100701_bib0001","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s10555-020-09925-3","article-title":"Gastric cancer: a comprehensive review of current and future treatment strategies","volume":"39","author":"Sexton","year":"2020","journal-title":"Cancer Metastasis Rev"},{"issue":"10","key":"10.1016\/j.clinsp.2025.100701_bib0002","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/CAD.0000000000001396","article-title":"Overexpression of lncRNA TCLlnc1 in gastric cancer predicts postoperative distant recurrence and poor survival","volume":"33","author":"Hu","year":"2022","journal-title":"Anticancer Drugs"},{"issue":"7","key":"10.1016\/j.clinsp.2025.100701_bib0003","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10147-019-01443-9","article-title":"Molecular carcinogenesis of gastric cancer: lauren classification, mucin phenotype expression, and cancer stem cells","volume":"24","author":"Oue","year":"2019","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.clinsp.2025.100701_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111158","article-title":"Role of lncRNA LUCAT1 in cancer","volume":"134","author":"Xing","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.clinsp.2025.100701_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106418","article-title":"Long non-coding RNA (lncRNA) H19 in human cancer: from proliferation and metastasis to therapy","volume":"184","author":"Hashemi","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.clinsp.2025.100701_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114407","article-title":"Long non-coding RNAs and gastric cancer: an update of potential biomarkers and therapeutic applications","volume":"163","author":"Hosseini","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.clinsp.2025.100701_bib0007","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.2147\/OTT.S217452","article-title":"Down-regulation of lncRNA LINC00152 suppresses gastric cancer cell migration and invasion through inhibition of the ERK\/MAPK signaling pathway","volume":"13","author":"Shi","year":"2020","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.clinsp.2025.100701_bib0008","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1476-4598-13-92","article-title":"Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer","volume":"13","author":"Liu","year":"2014","journal-title":"Mol Cancer"},{"issue":"16","key":"10.1016\/j.clinsp.2025.100701_bib0009","doi-asserted-by":"crossref","first-page":"26079","DOI":"10.18632\/oncotarget.15317","article-title":"Long non-coding RNA PTENP1 functions as a ceRNA to modulate PTEN level by decoying miR-106b and miR-93 in gastric cancer","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"issue":"17","key":"10.1016\/j.clinsp.2025.100701_bib0010","doi-asserted-by":"crossref","first-page":"17681","DOI":"10.18632\/aging.103876","article-title":"Long non-coding RNA Loc490 inhibits gastric cancer cell proliferation and metastasis by upregulating RNA-binding protein Quaking","volume":"12","author":"He","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.clinsp.2025.100701_bib0011","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3389\/fphar.2020.01112","article-title":"Construction and analysis of the tumor-specific mRNA\u2013miRNA\u2013lncRNA network in gastric cancer","volume":"11","author":"Zheng","year":"2020","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100701_bib0012","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1186\/s12885-021-08668-w","article-title":"LncRNA MCF2L-AS1 aggravates the malignant development of colorectal cancer via targeting miR-105-5p\/RAB22A axis","volume":"21","author":"Kong","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clinsp.2025.100701_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105655","article-title":"A lncRNA signature of tumor-infiltrating macrophages is associated with prognosis and tumor immunity in lung adenocarcinoma","volume":"148","author":"Guo","year":"2022","journal-title":"Comput Biol Med"},{"issue":"7","key":"10.1016\/j.clinsp.2025.100701_bib0014","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/tox.23142","article-title":"Long noncodingRNA MCF2L-AS1promotes the cancer stem cell-like traits in non-small cell lung cancer cells through regulatingmiR-873-5p level","volume":"36","author":"Li","year":"2021","journal-title":"Environ Toxicol"},{"issue":"1","key":"10.1016\/j.clinsp.2025.100701_bib0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: recent progress and future perspectives","volume":"16","author":"Guan","year":"2023","journal-title":"J Hematol Oncol"},{"issue":"23","key":"10.1016\/j.clinsp.2025.100701_bib0016","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.1158\/0008-5472.CAN-14-0686","article-title":"Long noncoding RNA GAPLINC regulates CD44-dependent cell invasiveness and associates with poor prognosis of gastric cancer","volume":"74","author":"Hu","year":"2014","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.clinsp.2025.100701_bib0017","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/febs.12625","article-title":"Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-myc mRNA stability","volume":"281","author":"Yang","year":"2014","journal-title":"FEBS J"},{"issue":"5","key":"10.1016\/j.clinsp.2025.100701_bib0018","doi-asserted-by":"crossref","first-page":"13437","DOI":"10.1080\/21655979.2022.2074108","article-title":"A high level of the long non-coding RNA MCF2L-AS1 is associated with poor prognosis in breast cancer and MCF2L-AS1 activates YAP transcriptional activity to enhance breast cancer proliferation and metastasis","volume":"13","author":"She","year":"2022","journal-title":"Bioengineered"},{"issue":"13","key":"10.1016\/j.clinsp.2025.100701_bib0019","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.18632\/aging.204795","article-title":"MCF2L-AS1 promotes the biological behaviors of hepatocellular carcinoma cells by regulating the miR-33a-5p\/FGF2 axis","volume":"15","author":"Ou","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.clinsp.2025.100701_bib0020","doi-asserted-by":"crossref","first-page":"8685","DOI":"10.2147\/CMAR.S313905","article-title":"lncRNA MCF2L-AS1\/miR-105\/IL-1\u03b2 axis regulates colorectal cancer cell oxaliplatin resistance","volume":"13","author":"Cai","year":"2021","journal-title":"Cancer Manag Res"},{"issue":"2","key":"10.1016\/j.clinsp.2025.100701_bib0021","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/carcin\/bgaa093","article-title":"LncRNA MCF2L-AS1 aggravates proliferation, invasion and glycolysis of colorectal cancer cells via the crosstalk with miR-874-3p\/FOXM1 signaling axis","volume":"42","author":"Zhang","year":"2021","journal-title":"Carcinogenesis"},{"issue":"30","key":"10.1016\/j.clinsp.2025.100701_bib0022","doi-asserted-by":"crossref","first-page":"10432","DOI":"10.3748\/wjg.v20.i30.10432","article-title":"MiRNA as potential biomarkers and therapeutic targets for gastric cancer","volume":"20","author":"Shin","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinsp.2025.100701_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113609","article-title":"LncRNA-miRNA axis in tumor progression and therapy response: an emphasis on molecular interactions and therapeutic interventions","volume":"154","author":"Entezari","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"1\u20132","key":"10.1016\/j.clinsp.2025.100701_bib0024","first-page":"28","article-title":"miR-503-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-A","volume":"29","author":"Wei","year":"2020","journal-title":"Gene Ther"},{"key":"10.1016\/j.clinsp.2025.100701_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.145068","article-title":"Circ_0010220-mediated miR-503-5p\/CDCA4 axis contributes to osteosarcoma progression tumorigenesis","volume":"763","author":"Li","year":"2020","journal-title":"Gene"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593225001206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593225001206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:01:42Z","timestamp":1790712102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593225001206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":25,"alternative-id":["S1807593225001206"],"URL":"https:\/\/doi.org\/10.1016\/j.clinsp.2025.100701","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression and clinical significance of MCF2L-AS1 in stomach adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinsp.2025.100701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 HCFMUSP. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100701"}}